SCP
WST icon

Sivia Capital Partners’s West Pharmaceutical WST Stock Holding History

Sivia Capital Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$361K Hold
1,006
– – 0.04% 420
2026
Q1 		$252K Sell
1,006
-158
-14% -$39.3K 0.05% 385
2025
Q4 		$320K Buy
1,164
+185
+19% +$50.6K 0.06% 383
2025
Q3 		$257K Buy
+979
New +$238K 0.07% 375

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Sivia Capital Partners's WST Position: Q2 2026 in Review

Sivia Capital Partners held its West Pharmaceutical (WST) position steady in Q2 2026 at 1,006 shares worth $361K. The position accounts for 0.04% of the portfolio, ranked #420.

Sivia Capital Partners first reported a position in WST in Q3 2025 and has held it in 4 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Sivia Capital Partners held 1,006 shares of West Pharmaceutical worth $361K as of Q2 2026.
  • Sivia Capital Partners left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up 0.04% of Sivia Capital Partners's portfolio in Q2 2026, its #420 holding.
  • Sivia Capital Partners first reported a position in West Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.